Lymphatic Metastasis - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Lymphatic Metastasis	go back to main search page
Accession:	RDO:0006041	browse the term
Definition:	Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
Synonyms:	exact_synonym:	Lymphatic Metastases
	primary_id:	MESH:D008207

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Lymphatic Metastasis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Axl	Axl receptor tyrosine kinase			ISS	1	80,964,751	80,994,300	RGD:2325833	RGD
G	Bag1	BCL2-associated athanogene		Disease_progression	ISS	5	58,329,720	58,342,293	RGD:2292908	RGD
G	Bcl2	B-cell CLL/lymphoma 2			ISS	13	12,730,736	12,905,108	RGD:2293013	RGD
G	Birc5	baculoviral IAP repeat-containing 5		Disease_progression	ISS				RGD:2293103	RGD
G	Birc5	baculoviral IAP repeat-containing 5			ISS				RGD:2293098	RGD
G	Bsg	basigin (Ok blood group)		Disease_progression	ISS	7	11,507,914	11,515,132	RGD:2289055	RGD
G	Car9	carbonic anhydrase 9			ISS	5	59,986,413	59,993,015	RGD:2293196	RGD
G	Ccne1	cyclin E1			ISS	1	90,568,189	90,577,426	RGD:2289266	RGD
G	Cd44	Cd44 molecule			ISS	3	88,022,962	88,110,352	RGD:2289356	RGD
G	Cdh1	cadherin 1			ISS	19	36,442,693	36,512,091	RGD:2289498	RGD
G	Cdh1	cadherin 1			ISS	19	36,442,693	36,512,091	RGD:2296046	RGD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B			ISS	4	171,841,705	171,846,506	RGD:2293607	RGD
G	Csf1r	colony stimulating factor 1 receptor			ISS	18	57,080,324	57,107,295	RGD:2293711	RGD
G	Ctla4	cytotoxic T-lymphocyte-associated protein 4			ISS	9	59,495,773	59,501,300	RGD:4891523	RGD
G	Ctnna1	catenin (cadherin-associated protein), alpha 1, 102kDa			ISS	18	27,629,915	27,769,360	RGD:2289795	RGD
G	Ctnnb1	catenin (cadherin associated protein), beta 1			ISS	8	125,978,161	125,987,670	RGD:2289813	RGD
G	Ebag9	estrogen receptor binding site associated, antigen, 9			ISS	7	80,515,272	80,533,346	RGD:2298489	RGD
G	Ebag9	estrogen receptor binding site associated, antigen, 9			ISS	7	80,515,272	80,533,346	RGD:2289856	RGD
G	Ebag9	estrogen receptor binding site associated, antigen, 9			ISS	7	80,515,272	80,533,346	RGD:2289847	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			ISS	10	87,219,157	87,242,919	RGD:2289926	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			ISS	10	87,219,157	87,242,919	RGD:2289925	RGD
G	Erbb3	v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			ISS	7	1,858,057	1,877,353	RGD:2289944	RGD
G	Fas	Fas cell surface death receptor		Susceptibility	ISS	1	238,259,443	238,274,745	RGD:2298509	RGD
G	Fgf1	fibroblast growth factor 1 (acidic)			ISS	18	31,785,480	31,806,452	RGD:2290286	RGD
G	Figf	c-fos induced growth factor			ISS	X	50,830,612	50,864,445	RGD:2315480	RGD
G	Figf	c-fos induced growth factor			ISS	X	50,830,612	50,864,445	RGD:2315475	RGD
G	Flt3	fms-related tyrosine kinase 3		Disease_progression	ISS	12	8,193,629	8,268,682	RGD:2302210	RGD
G	Mmp9	matrix metallopeptidase 9		Disease_progression	IEP	3	155,985,473	155,993,433	RGD:5129215	RGD
G	Mmp9	matrix metallopeptidase 9			ISS	3	155,985,473	155,993,433	RGD:2298523	RGD
G	Muc1	mucin 1, cell surface associated			ISS	2	181,399,482	181,403,640	RGD:2324649	RGD
G	Muc1	mucin 1, cell surface associated			ISS	2	181,399,482	181,403,640	RGD:2324860	RGD
G	Muc5ac	mucin 5AC, oligomeric mucus/gel-forming			ISS				RGD:2325168	RGD
G	Ncam1	neural cell adhesion molecule 1			ISS	8	52,822,350	53,120,572	RGD:2326067	RGD
G	Nme1	NME/NM23 nucleoside diphosphate kinase 1			ISS	10	82,591,705	82,601,075	RGD:2299061	RGD
G	Nme1	NME/NM23 nucleoside diphosphate kinase 1			ISS	10	82,591,705	82,601,075	RGD:2299077	RGD
G	Nme1	NME/NM23 nucleoside diphosphate kinase 1			ISS	10	82,591,705	82,601,075	RGD:2299062	RGD
G	Nme2	NME/NM23 nucleoside diphosphate kinase 2			ISS	10	82,582,766	82,588,269	RGD:2299062	RGD
G	Nos3	nitric oxide synthase 3, endothelial cell		Susceptibility	ISS	4	6,158,847	6,179,441	RGD:2292070	RGD
G	Pdgfa	platelet-derived growth factor alpha polypeptide			ISS	12	16,151,045	16,172,412	RGD:2292155	RGD
G	Pdgfb	platelet-derived growth factor beta polypeptide			ISS	7	118,244,385	118,262,021	RGD:2292173	RGD
G	Pdpn	podoplanin			ISS	5	162,142,251	162,175,921	RGD:2292231	RGD
G	Pdpn	podoplanin			ISS	5	162,142,251	162,175,921	RGD:2292237	RGD
G	Pebp1	phosphatidylethanolamine binding protein 1			ISS	12	40,491,393	40,495,593	RGD:2302868	RGD
G	Pebp1	phosphatidylethanolamine binding protein 1			ISS	12	40,491,393	40,495,593	RGD:2302867	RGD
G	Pou5f1	POU class 5 homeobox 1			ISS				RGD:2292442	RGD
G	Pparg	peroxisome proliferator-activated receptor gamma			ISS	4	151,492,220	151,617,331	RGD:2317459	RGD
G	Prex1	phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1			ISS	3	157,693,897	157,863,943	RGD:2314605	RGD
G	Pten	phosphatase and tensin homolog			ISS	1	236,771,027	236,837,261	RGD:2292507	RGD
G	Pten	phosphatase and tensin homolog			ISS	1	236,771,027	236,837,261	RGD:2292499	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	13	64,427,288	64,432,978	RGD:5135471	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	13	64,427,288	64,432,978	RGD:2317165	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	13	64,427,288	64,432,978	RGD:2300128	RGD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)			ISS	1	208,262,669	208,273,148	RGD:2298757	RGD
G	Ret	ret proto-oncogene			ISS	4	154,448,179	154,491,103	RGD:2324925	RGD
G	Rhoa	ras homolog family member A			ISS				RGD:2298872	RGD
G	Skp2	S-phase kinase-associated protein 2, E3 ubiquitin protein ligase			ISS	2	58,769,164	58,797,229	RGD:2315043	RGD
G	Smad4	SMAD family member 4			ISS	18	70,432,705	70,461,541	RGD:2300007	RGD
G	Sncg	synuclein, gamma (breast cancer-specific protein 1)			ISS	16	10,025,978	10,030,516	RGD:6478801	RGD
G	Socs2	suppressor of cytokine signaling 2			ISS	7	32,605,714	32,608,323	RGD:2298925	RGD
G	Socs3	suppressor of cytokine signaling 3			ISS	10	107,958,468	107,959,330	RGD:2298901	RGD
G	St14	suppression of tumorigenicity 14 (colon carcinoma)			ISS	8	30,916,769	30,932,214	RGD:2315087	RGD
G	Stk11	serine/threonine kinase 11			ISS	7	11,086,760	11,103,522	RGD:2291948	RGD
G	Timp1	TIMP metallopeptidase inhibitor 1			ISS	X	12,542,496	12,547,094	RGD:2298523	RGD
G	Timp3	TIMP metallopeptidase inhibitor 3			ISS	7	19,677,144	19,727,072	RGD:2290437	RGD
G	Timp4	tissue inhibitor of metalloproteinase 4			ISS	4	151,375,072	151,381,591	RGD:2290437	RGD
G	Tp53	tumor protein p53			ISS	10	56,399,721	56,411,150	RGD:2290534	RGD
G	Tp53	tumor protein p53			ISS	10	56,399,721	56,411,150	RGD:2290533	RGD
G	Tymp	thymidine phosphorylase			ISS	7	127,666,518	127,671,624	RGD:2325027	RGD
G	Tymp	thymidine phosphorylase			ISS	7	127,666,518	127,671,624	RGD:2293725	RGD
G	Vegfa	vascular endothelial growth factor A			ISS	9	10,520,730	10,536,071	RGD:2315454	RGD
G	Vegfc	vascular endothelial growth factor C			ISS	16	40,624,435	40,739,692	RGD:2315475	RGD
G	Vegfc	vascular endothelial growth factor C			ISS	16	40,624,435	40,739,692	RGD:2315474	RGD
G	Vegfc	vascular endothelial growth factor C			ISS	16	40,624,435	40,739,692	RGD:2315469	RGD
G	Vegfc	vascular endothelial growth factor C			ISS	16	40,624,435	40,739,692	RGD:2315484	RGD

Term paths to the root

Path 1
Term	Annotations
Diseases	30711
Neoplasms	5216
Neoplastic Processes	212
Neoplasm Metastasis	208
Lymphatic Metastasis	74
Path 2
Term	Annotations
Diseases	30711
Pathological Conditions, Signs and Symptoms	5181
Pathologic Processes	2238
Neoplastic Processes	212
Neoplasm Metastasis	208
Lymphatic Metastasis	74